Good sharing and updating Yes if we want to prevent cervical cancers vaccine is proved and well accepted
Vaccine should not be promoted as cervical cancer vaccine It prevent HPVirus infection and Genital warts. Can by prevent infection reduces chanes of cervical cancer.
Excellent -innovation -flowers of Parijatham(telugu)with stalk-juice obtained has shown GIA( Growth inhibiting activity in vitro expt _ an ointment using the juice -worth to put in clinical trial for Cervical erosion(pre cancerous) comparitive study with standard treated Qs wll be answered-Dr insira
Informative and educative post.
Usefull Update regarding HPV VACCINATION .
Yes it's very imp
VERY USEFUL AND INFORMATIVE NICELY. UPDATED
Agar Ham Sare Sharir Ko Chhod Dete Hain acid Khatam kar dete Hain Kisi bhi Bimari ko khatm kar sakte hain Bimari jaldi theek ho Jaati Hai vah truck ok ho jata hai Khoon saaf ho jata hai ho jata hai Bimari theek ho
Cases that would interest you
- Login to View the image
36 years male Asymptomatic multiple grouped warty lesions on g right side glans and coronal areas since 1 month. History of extramarital contact 1 month 10 days . Married regular contact with wife also. What is the diagnosis ? How to manage this case?Dr. P.kishore Kumar3 Likes22 Answers
- Login to View the image
Friends today I am discussing about a serious problem known as Genital warts. 1. Genital warts are caused by the human papillomavirus (HPV). 2. Genital warts affect both women and men, but women are more vulnerable to complications. 3. Genital warts can be treated, but they can come back unless the underlying infection is also treated. What are genital warts? Genital warts are soft growths that appear on the genitals. They’re a sexually transmitted infection (STI) caused by certain strains of the human papillomavirus (HPV). Genital warts can cause pain, discomfort, and itching. They’re especially dangerous for women because some types of HPV can also cause cancer of the cervix and vulva. HPV is the most common of all STIs. Men and women who are sexually active are vulnerable to complications of HPV, including genital warts. Treatment is key in managing this infection. Pictures of genital warts Contains Graphic Imagery What are the symptoms of genital warts? Genital warts are transmitted through sexual activity, including oral, vaginal, and anal sex. You may not start to develop warts for several weeks or months after infection. Genital warts are not always visible to the human eye. They may be very small and the color of the skin or slightly darker. The top of the growths may resemble a cauliflower and may feel smooth or slightly bumpy to the touch. They may occur as a cluster of warts, or just one wart. Genital warts on males may appear on the following areas: penis scrotum groin thighs inside or around the anus Genital warts in females may appear on the following area: inside of the vagina or anus outside of the vagina or anus cervix Genital warts may also appear on the lips, mouth, tongue, or throat of a person who has had oral sexual contact with an infected person. Even if you cannot see genital warts, they may still cause symptoms, such as: vaginal discharge itching bleeding burning If genital warts spread or become enlarged, the condition can be uncomfortable or even painful. What causes genital warts? Most cases of genital warts are caused by HPV. There are 30 to 40 strains of HPV that specifically affect the genitals, but just a few of these strains cause genital warts. The HPV virus is highly transmittable through skin-to-skin contact, which is why it’s considered an STI. In fact, HPV is so common that the Centers for Disease Control and Prevention (CDC) says that most sexually active people get it at some point. However, the virus doesn’t always lead to complications such as genital warts. In fact, in most cases, the virus goes away on its own without causing any health problems. Genital warts are caused by strains of HPV that differ from the strains that cause warts on your hands or other parts of the body. A wart can’t spread from someone’s hand to the genitals, and vice versa. Risk factors for genital warts Any sexually active person is at risk of getting HPV. However, genital warts are more common for people who: are under the age of 30 smoke have a weakened immune system have a history of child abuse are children of a mother who had the virus during childbirth What are other possible complications of HPV? HPV is the main cause of cancer in the cervix. It can also cause precancerous changes to the cells of the cervix, which is called dysplasia. Other types of HPV may also cause cancer of the vulva, which are the external genital organs of women. They can also cause penile and anal cancer. How are genital warts diagnosed? To diagnose this condition, your doctor will ask questions about your health and sexual history. This includes symptoms you’ve experienced and any times you’ve engaged in unprotected sex, including oral sex. Your doctor will also perform a physical examination of any areas where you suspect warts may be occurring. For women only Because warts can occur deep inside a woman’s body, your doctor may need to do a pelvic examination. They may apply a mild acidic solution, which helps to make the warts more visible. Your doctor may also do a Pap smear, which involves taking a swab of the area to obtain cells from your cervix. These cells can then be tested for the presence of HPV. Certain types of HPV may cause abnormal results on a Pap smear, which may indicate precancerous changes. If your doctor detects these abnormalities, you may need more frequent screenings to monitor any changes. If you’re a woman and concerned that you may have contracted a form of HPV known to cause cervical cancer, your doctor can perform a DNA test. This determines what strain of HPV you have in your system. An HPV test for men is not yet available. How are genital warts treated? While visible genital warts often go away with time, HPV itself can linger in your bloodstream. This means you may have several outbreaks over the course of your life. This makes managing symptoms important because you want to avoid transmitting the virus to others. That said, genital warts can be passed on to others even when there are no visible warts or other symptoms. You may wish to treat genital warts to relieve painful symptoms or to minimize their appearance. However, you cannot treat genital warts with over-the-counter (OTC) wart removers or treatments. Your doctor may prescribe topical wart treatments that might include: imiquimod (Aldara) podophyllin and podofilox (Condylox) trichloroacetic acid (TCA) If visible warts don’t go away with time, you may need minor surgery to remove them. Your doctor can also remove the warts through: electrocautery, or burning warts with electric currents cryosurgery, or freezing warts laser treatments excision, or cutting off warts injections of the drug interferon Women who have been diagnosed with genital warts may need to have Pap smears every three to six months after their initial treatment. This allows your doctor to monitor any changes in your cervix. Monitoring is important because you may be at higher risk of cervical cancer. The strains of HPV that cause genital warts are considered low-risk for progression into cancer. However, you could have other HPV strains as well, some of which may increase your risk of cancer. Home remedies for genital warts You should not use OTC treatments meant for hand warts on genital warts. Hand and genital warts are caused by different strains of HPV. Using the wrong treatments may do more harm than good. Some home remedies are touted as helpful in treating genital warts, but there is little evidence to support them. Always check with your doctor before trying a home remedy. How to prevent genital warts HPV vaccines called Gardasil and Gardasil 9 can protect men and women from the most common HPV strains that cause genital warts, and can also protect against strains of HPV that are linked to cervical cancer. A vaccine called Cervarix is also available. This vaccine protects against cervical cancer, but not against genital warts. Individuals up to age 26 years can receive the HPV vaccine. It can also be given as early as age 9, and comes in a round of three different shots. Both types of vaccine should be given before the person becomes sexually active, as they’re most effective before a person is exposed to HPV. Using protection every time you have sex can also reduce your risk of contracting genital warts. This can mean using a condom or a dental dam. Coping and outlook Genital warts are a complication of HPV infection that’s common and treatable. They can disappear over time, but treatment is essential in preventing their return and possible complications. AURUM MURIATICUM 30- Aurum muriaticum is for treating warts on genitals and tongue. CARBO ANIMALIS 30-Carbo animalis is for treating warts on hands face of old people. CASTOREUM CAN. 30- Castoreum can is for warts on forehead. CALCAREA CARBONICA 30-Calcare carb is for treating warts on face and hands.Dr. Rajesh Gupta17 Likes26 Answers
- Login to View the image
22yr unmarried girl came with c/o itching and irritation over Pvt part give opinion on diagnosis and managementDr. Jyoti Meravi19 Likes186 Answers
- Login to View the image
PARENTS WANT THE HPV VACCINE FOR THEIR SON – NEW RESEARCH. April 12, 2018. HUMAN PAPILLOMAVIRUS (HPV) is a SEXUALLY TRANSMITTED infection that causes diseases that AFFECT BOTH MEN AND WOMEN. IN the UK, GIRLS ARE VACCINATED AGAINST HPV BUT BOYS ARE NOT. There are MORE THAN 100 TYPES of HPV. TWO of the LOW RISK TYPES (six AND 11) CAUSE more than 90% of GENITAL WARTS. Other HIGH RISK TYPES OF HPV (ESPECIALLY 16 AND 18) can CAUSE CERVICAL, VULVAL, VAGINAL, HEAD, NECK and THROAT, ANAL AND PENILE CANCERS. While the INCIDENCE OF CERVICAL CANCER IN the UK has FALLEN since the 1990s, thanks to the NHS cervical screening programme, the INCIDENCE OF THOSE CANCERS THAT AFFECT BOTH MEN AND WOMEN IS ON THE RISE. More than 80% OF SEXUALLY ACTIVE PEOPLE will be EXPOSED TO HPV IN THEIR LIFETIME. GENITAL HPV infection is SPREAD DURING SEXUAL INTERCOURSE AND SKIN-TO-SKIN CONTACT OF the GENITAL AREAS. Wearing a CONDOM REDUCES the RISK of infection BUT does NOT PROVIDE COMPLETE PROTECTION. ONCE a person has been INFECTED, their IMMUNE SYSTEM will FIGHT THE VIRUS AND, in MOST CASES, the virus will have NO ILL EFFECTS. BUT, for SOME PEOPLE, the virus will PROGRESS TO cause WARTS OR CANCER. Since 2008, 12- AND 13-YEAR-OLD GIRLS IN most of the UK (11 TO 13 in SCOTLAND) have been OFFERED the CHANCE TO be VACCINATED AGAINST HPV via a school-based programme. In a phased rollout FROM APRIL 2018, MEN AGED 45 OR YOUNGER WHO HAVE SEX WITH MEN WILL BE OFFERED the HPV VACCINATION IN ENGLAND at sexual health clinics and HIV clinics, BRINGING ENGLAND IN LINE WITH THE REST OF THE UK. BUT BOYS ARE NOT LIKELY TO BE OFFERED THE HPV VACCINE ANY TIME SOON. TOO LITTLE, TOO LATE : ONE RATIONALE FOR NOT VACCINATING BOYS is that IF ENOUGH GIRLS ARE VACCINATED (currently, around 85% of girls have the necessary two doses in England), THIS PROVIDES "HERD IMMUNITY" to men, MEANING that IF WOMEN DON'T HAVE THE VIRUS, MEN WILL NOT be able to CATCH IT either. The main PROBLEM WITH the HERD IMMUNITY ARGUMENT, when it is girls rather than boys who are vaccinated, is that IT DOESN'T PROVIDE PROTECTION FOR MEN WHO HAVE SEX WITH MEN, OR for MEN who HAVE SEX WITH UNVACCINATED WOMEN – for EXAMPLE, WOMEN FROM COUNTRIES WITHOUT a VACCINATION programme, OR WOMEN who are TOO OLD TO have been ELIGIBLE FOR the VACCINATION. MEN who have SEX WITH MEN are particularly VULNERABLE TO HPV-RELATED ANAL CANCER. ALTHOUGH THEY can now OPT to have the VACCINATION, IT IS TOO LITTLE, TOO LATE. The HPV VACCINATION is MOST EFFECTIVE WHEN it is GIVEN BEFORE EXPOSURE to the virus (before sexual activity starts), and also when it is given BEFORE PUBERTY, when immune systems are able to PROVIDE a STRONGER ANTIBODY RESPONSE. GENDER-NEUTRAL VACCINATION HAS WIDE SUPPORT AMONG the MEDICAL COMMUNITY with professional organisations such as the British Dental Association and The Faculty of Public Health FAVOURING VACCINATION FOR BOTH BOYS AND GIRLS. SURVEY RESULTS : It is not just professionals who want to see the vaccination extended to boys. A RECENT Wellcome-funded SURVEY OF 186 PARENTS OF TEENAGE BOYS in North Staffordshire that we conducted FOUND that many of the PARENTS were NOT AWARE of the health CONSEQUENCES OF HPV FOR MEN. The research, published in PLOS ONE, revealed that ONCE they were PROVIDED with this INFORMATION, however, MOST PARENTS WANTED THE VACCINE TO BE AVAILABLE TO THEIR SONS. SEVERAL COUNTRIES VACCINATE BOTH GIRLS AND BOYS AGAINST HPV, INCLUDING the US, CANADA, AUSTRIA, AUSTRALIA and NEW ZEALAND. IT IS UNACCEPTABLE, AS SOCIETY STRIVES FOR EQUALITY in so many areas, THAT the UK should NOT EXTEND the PROTECTION afforded BY the HPV VACCINATION TO BOYS AS WELL AS GIRLS. $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$ This article was originally published on The Conversation. Read the original article.The Conversation PROVIDED BY : The Conversation. ________________________________ IMAGE : HPV CAUSES a range of CANCERS, including CERVICAL, PENILE, ANAL AND THROAT CANCER. .................................................................................. CREDIT: Tatiana Shepeleva/Shutterstock.com. **************************+***************************Dr. Puranjoy Saha17 Likes10 Answers
- Login to View the image
HPV VACCINE IS EFFECTIVE, SAFE 10 YEARS AFTER IT'S GIVEN. November 29, 2017. A DECADE OF DATA ON HUNDREDS OF BOYS AND GIRLS WHO RECEIVED THE HPV VACCINE INDICATES the VACCINE IS SAFE AND EFFECTIVE LONG TERM IN PROTECTING AGAINST THE MOST VIRULENT STRAINS OF THE VIRUS, researchers report. The findings support more widespread and EARLY ADMINISTRATION OF the HPV VACCINE before preadolescents and adolescents are exposed to the nation's most common sexually transmitted infection and the most common cause of cervical cancer, they report in the journal Pediatrics. SOME 79 MILLION AMERICANS, MOST IN their LATE TEENS AND EARLY 20s, ARE INFECTED WITH HUMAN PAPILLOMAVIRUS, according to the Centers for Disease Control and Prevention. ABOUT HALF of those are INFECTED WITH the MOST VIRULENT STRAINS of the virus, which are TARGETED BY the QUADRIVALENT VACCINE given to study participants. "The VACCINE was VIRTUALLY 100 PERCENT EFFECTIVE IN PREVENTING DISEASE in these young individuals," says Dr. Daron G. Ferris, professor in the Department of Obstetrics and Gynecology at the Medical College of Georgia and at the Georgia Cancer Center at Augusta University. The QUADRIVALENT VACCINE PROTECTS AGAINST HPV TYPES 6, 11, 16 AND 18. TYPES 16 AND 18 ACCOUNT FOR ESSENTIALLY ALL CERVICAL CANCER and for most other HPV-related cancers like PENILE AND ANAL CANCERS, according to the National Cancer Institute. TYPES 6 AND 11 ACCOUNT FOR ABOUT 90 PERCENT of GENITAL WARTS as well as NON-CANCEROUS TUMOR GROWTHS IN THE RESPIRATORY TRACT. NO cases of DISEASE related to these four HPV types were FOUND IN study PARTICIPANTS, who RECEIVED a THREE-DOSE REGIMEN of the VACCINE WHEN THEY WERE AGES 9-15 AND SEXUALLY INACTIVE, Ferris says. Ferris, first author of the new study who led trials of the quadrivalent vaccine in 2002, says the earlier, shorter-term evaluation clearly indicated the vaccine worked. "We also needed to look at long-term efficacy, safety and immunogenicity," he says. "We needed to answer questions like IF we VACCINATE EARLIER IN LIFE, WILL IT LAST. The ANSWER IS YES, this cancer prevention VACCINE is WORKING INCREDIBLY WELL 10 YEARS LATER. A BOOSTER vaccine LIKELY will NOT be NEEDED by these young people. I think now we have come full circle." THE STUDY WAS THE LONGEST FOLLOW UP TO DATE ON THE VACCINE. Follow-up data on safety and efficacy has been assessed at up to six years in women age 15-26 and the current team of investigators also looked at data on the large cohort of young people two years ago. PARTICIPANTS were followed at 34 SITES IN NINE COUNTRIES, including MCG and the Georgia Cancer Center in Augusta. Initially about one third of the 1,661 study participants received placebo, however the PLACEBO GROUP ALSO RECEIVED the VACCINE 30 months into the study SO those individuals were followed a shorter period of time, the researchers note. While ALL PARTICIPANTS REMAINED DISEASE FREE, the EARLIER VACCINATIONS PRODUCED the most robust initial and LONG-TERM ANTIBODY RESPONSE, Ferris says, of levels of the infection fighters that can be measured in the blood. While about TWO-THIRDS of INFECTED INDIVIDUALS can eventually CLEAR THE VIRUS, it persists and can cause a wide range of health problems in the remainder, Ferris says. The vaccination is designed to better arm everyone's immune system to eliminate the virus. The Food and Drug Administration (FDA) APPROVED THE FIRST QUADRIVALENT VACCINE, Gardasil, in June 2006. The vaccine is CURRENTLY APPROVED FOR PATIENTS AGES 9-26. EFFECTIVENESS assessments included looking for genital warts, precancerous and cancerous growths on the cervix and genitals as well as persistent HPV infections. Effectiveness EVALUATION began at 3.5 years and continued twice yearly during the 10-year-period. TWO-DOSE VACCINES THAT COVER NINE HPV STRAINS ARE RAPIDLY REPLACING THE THREE-DOSE QUADRIVALENT VACCINE, Ferris says. "Now we need to push for more young people to get vaccinated," he says. "We are doing miserably in the United States." About 43 PERCENT of U.S. TEENS are up to date ON RECOMMENDED DOSES of the HPV vaccine, according to the CDC. THE HPV VACCINE CAN BE GIVEN ALONG WITH the MENINGOCOCCAL AND TETANUS, DIPHTHERIA AND PERTUSSIS VACCINES, to 11- and 12-year-olds, the researchers note. Study PARTICIPANTS reported SEXUAL ACTIVITY RATES SIMILAR to other studies and numbers of new sexual partners were higher among males than females. OTHER sexually transmitted diseases, including GONORRHEA and CHLAMYDIA, were FOUND in a SMALL PERCENTAGE of study participants over the years of follow up. HALF OF ALL SEXUALLY TRANSMITTED DISEASES OCCUR IN PEOPLE AGE 15-24 AND 1 IN 4 SEXUALLY ADOLESCENT FEMALES HAVE a sexually transmitted disease like CHLAMYDIA or HPV, ACCORDING TO the CDC. $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$ PROVIDED BY: Medical College of Georgia at Augusta University. ________________________________ IMAGE : 1 A decade of data on hundreds of boys and girls who received the HPV vaccine indicates the vaccine is safe and effective long term in protecting against the most virulent strains of the virus, researchers report. CREDIT: Phil Jones, Senior Photographer, Augusta University. IMAGE : 2 Electron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. CREDIT: public domain. 3. Women can reduce their risk of cervical cancer through vaccination and screening, the U.S. Food and Drug Administration says. *************************×**************************** EXPLORE FURTHER : 1. New study finds improved vaccine that protects against nine types of HPV is highly effective. September 6, 2017 PROVIDED BY: H. Lee Moffitt Cancer Center & Research Institute 2. Vaccine to prevent most cervical cancers shows long-term effectiveness. September 6, 2017. Warner K Huh et al, Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial, The Lancet (2017). DOI: 10.1016/S0140-6736(17)31821-4 PROVIDED BY: University of Alabama at Birmingham. 3. Screening, HPV vaccine can prevent cervical cancer: FDA February 8, 2017 4. American Cancer Society endorses two-dose regimen for HPV vaccination. Cancer Screening in the United States, 2017: A Review of Current American Cancer Society Guidelines and Current Issues in Cancer Screening, Smith et al. CA: Can J Clin. DOI: 10.3322/caac.21392 PROVIDED BY: American Cancer Society -----------------------------------------------------------Dr. Puranjoy Saha17 Likes9 Answers